ArticlePloS one2016

Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.

Steven M Szczepanek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.